Why a Pfizer Takeover of Bristol-Myers Squibb Seems Unlikely - BNET
30 Nov
Posted by: admin in: Pharmaceutical Companies
|
Why a Pfizer Takeover of Bristol-Myers Squibb Seems Unlikely
BNET, Ca - 14 hours ago But results from apixaban have been mixed: Bristol-Myers Squibb and its development partner Pfizer announced in August that the primary endpoint was not met … |
Search
Categories
- Canadian Pharmacy (160)
- Health News (1954)
- Online Pharmacy (174)
- Pharmaceutical Companies (1016)
- Pharmacy News (291)
- Pharmacy Technician (182)
Leave a reply